Kaplan Fox Continues to Investigate Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) - INVESTOR UPDATE
02. Dezember 2022 15:32 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing to investigate claims on behalf of investors in Spectrum Pharmaceuticals, Inc....
SPECTRUM PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Spectrum Pharmaceuticals Inc. Investors of the Lead Plaintiff Deadline in Securities Class Action
08. November 2016 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) of the securities class action lawsuit and...
SPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Spectrum Pharmaceuticals Inc. Investors to Expanded Class Period and Lead Plaintiff Deadline
05. Oktober 2016 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 05, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) to the expanded class period in the Nevada U.S....